Panion & BF Biotech Inc
TWSE:1760
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| TW |
|
Panion & BF Biotech Inc
TWSE:1760
|
5.4B TWD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.1B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -22 082.4% |
| 30th Percentile | 1% |
| Median | 5.3% |
| 70th Percentile | 11.1% |
| Max | 1 580% |
Other Profitability Ratios
Panion & BF Biotech Inc
Glance View
Panion & BF Biotech, Inc. engages in the manufacturing and sales of medicines, cosmetics, and formula foods. The company is headquartered in Taipei City, Taipei. The company went IPO on 2004-06-14. The firm is also involved in the manufacture and sales of various kinds of cosmetics. The firm's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The firm also provides biotechnology services. The firm distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Panion & BF Biotech Inc is 8.6%, which is above its 3-year median of 6.5%.
Over the last 3 years, Panion & BF Biotech Inc’s Net Margin has decreased from 11.4% to 8.6%. During this period, it reached a low of 3.5% on Sep 30, 2023 and a high of 13.9% on Mar 31, 2023.
